BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/29/2024 8:12:47 AM | Browse: 49 | Download: 0
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chun-Yao Cheng, Wen-Rui Hao, Ju-Chi Liu and Tzu-Hurng Cheng |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung City 404333, Taiwan. thcheng@mail.cmu.edu.tw |
| Key Words |
Diabetic cardiomyopathy; Teneligliptin; Nucleotide-binding oligomerization domain-like receptor 3 inflammasome; Inflammasome inhibition |
| Core Tip |
Teneligliptin can mitigate diabetic cardiomyopathy (DCM) by inhibiting NOD-like receptor protein 3 inflammasome activation and upregulating AMP-activated protein kinase signaling. This study provides insights into the molecular mechanisms underlying the beneficial effects of teneligliptin for the treatment of DCM. |
| Citation |
Cheng CY, Hao WR, Liu JC, Cheng TH. Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies. World J Diabetes 2024; 15(12): 2370-2375 |
 |
Received |
|
2024-03-11 23:30 |
|
Peer-Review Started |
|
2024-03-11 23:30 |
|
First Decision by Editorial Office Director |
|
2024-09-19 09:17 |
|
Return for Revision |
|
2024-09-19 09:17 |
|
Revised |
|
2024-09-27 16:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-10-29 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-29 08:12 |
|
Articles in Press |
|
2024-10-29 08:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-05 08:45 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
